Navigation Links
The Leukemia & Lymphoma Society: Impacting Blood Cancers and Beyond
Date:2/19/2013

WHITE PLAINS, N.Y., Feb. 19, 2013 /PRNewswire/ -- In 1964, the five-year survival rate for the most common form of childhood leukemia was only three percent but, today, thanks to treatment advances, about 90 percent of children survive. As the leading global non-profit organization dedicated to curing blood cancers, The Leukemia & Lymphoma Society (LLS) has invested nearly one billion dollars in blood cancer research since 1954, bringing us closer than ever to realizing a world without blood cancers.

(Photo:  http://photos.prnewswire.com/prnh/20130219/NY61444 )

LLS has achieved its leadership position through a unique approach to research and fundraising. Its venture philanthropy model forges partnerships with pharmaceutical and biotechnology companies, academia, medical centers and the National Institutes of Health, to foster the process of drug discovery from basic research to translational and clinical research. Rather than duplicate what the federal government is funding, LLS developed its own research agenda to accelerate the development of promising new life-saving therapies with a focus on un-met medical need.

"We're not your grandfather's charity," proclaims Louis DeGennaro , PhD, LLS chief mission officer. "There is no means of preventing or early screening for blood cancers, so our focus is on life-saving research to find cures. LLS research funding has touched the discovery or development of nearly every therapy used in the battle against blood cancers – including targeted drugs, like Gleevec®, Velcade® and Kyprolis™, and immunotherapies, like Rituxan®."

In fact, LLS is playing a unique role in the pathway to cures, especially for a non-profit organization.  Blood cancers, which include leukemia, lymphoma, myeloma and myelodysplastic syndromes, are hema
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Data Presented at American Society of Hematology from Ibrutinib Phase 1b/2 and Phase 2 Trials Suggest High and Durable Response in Chronic Lymphocytic Leukemia
2. Stemline Therapeutics, Inc. Announces Presentations of SL-401 Updated Clinical Trial Results in Acute Myeloid Leukemia (AML) and Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) and SL-101 Preclinical Efficacy Data Against Hodgkins Lymphoma at
3. Inovio Pharmaceuticals Announces Positive Interim Results in Phase II Leukemia Trial
4. Global Acute Myeloid Leukemia (AML) Therapeutics Industry
5. The Leukemia & Lymphoma Society Awards $12 Million in Research Grants in Four Critical Areas of Unmet Medical Need
6. Karyopharm Therapeutics announces the Publication of Two Preclinical Studies on the Activity of Selective Inhibitors of Nuclear Export (SINE) in Acute Myeloblastic Leukemia (AML)
7. Study of Cell Therapeutics Tosedostat for Elderly Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Now Enrolling
8. Acute Lymphocytic Leukemia: Impressive Results With the Monoclonal Antibody Blinatumomab in Patients With Refractory Disease
9. How Malignant Cells in Patients With Chronic Lymphocytic Leukemia Escape T Cell Recognition and Attack
10. Founder of National Childrens Leukemia Unveiled Non-Embryonic Stem Cell Treatment Promising Cure for Cancer at GIL 2012: Europe
11. Roche Launches 454 Sequencing Assays for High Sensitivity Genetic Variant Detection in Leukemia Samples to Drive Blood Cancer Research Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... BANGALORE, India , July 1, 2015 /PRNewswire/ ... uses next generation sequencing technology to empower cancer care, ... as chief executive officer. In his expanded role ... for all strategy, business expansion and worldwide operations effective ... as Strand,s chairman and CEO since its founding in ...
(Date:7/1/2015)... , July 1, 2015 ... technology will ... s evidence-based clinical s olutions suite   ... technical and medical information products and services, announced today the ... clinical decision support (CDS) technology company. InferMed,s Arezzo ...
(Date:6/30/2015)... ... June 30, 2015 , ... Students ... part in the first half of “Integrative Biotechnology,” an applied biotechnology course team-taught ... summer 2014, this course combines students from both universities and is taught on ...
(Date:6/30/2015)... 2015  Today, Americord Registry, one of the fastest growing ... , a partner at Kirkland & Ellis LLP, as the ... - http://photos.prnewswire.com/prnh/20150630/226958LOGO   "We are thrilled about ... Martin Smithmyer , CEO of Americord. "He brings a ... will assist Americord,s growth and vision." Andrew ...
Breaking Biology Technology:Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4Rivier University and Beijing City University Academic and Cultural Exchanges Begin 2Americord Registry Announces Andrew Horne as Advisory Board Member 2
... LYNBROOK, N.Y., Aug. 11 BioSpecifics,Technologies Corp. (OTC Bulletin ... products, today,announced its financial results for the second quarter ... net loss of $801,337 for the quarter ended June,30, ... to a net loss of,$478,000, or 9 cents per ...
... Conference Call Today at 5:00 p.m. EDT -, ... ) today reported financial results for the second,quarter ended ... 2008, total operating expenses were $80.9,million, compared to $75.4 ... primarily attributable to increased research and development,(R&D) expenses which ...
... (Amex: IMM ) today announced results for its ... months ended June 30, 2008, revenues were $1,141,000, as,compared ... 2007. The increase,was primarily attributable to revenues from a ... months ended June 30, 2008,was $1,278,000, as compared to ...
Cached Biology Technology:BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results 2BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results 3BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results 4BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results 5BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results 6MannKind Corporation Reports Second Quarter Financial Results 2MannKind Corporation Reports Second Quarter Financial Results 3MannKind Corporation Reports Second Quarter Financial Results 4MannKind Corporation Reports Second Quarter Financial Results 5MannKind Corporation Reports Second Quarter Financial Results 6Immtech Reports Fiscal First Quarter 2009 Results 2Immtech Reports Fiscal First Quarter 2009 Results 3
(Date:6/16/2015)... Sweden , June 16, 2015 ... all touch fingerprint sensors in the company,s portfolio from one ... Deliveries are planned to mainly take place during the third ... in Asia . Jörgen Lantto, ... evidence of    the   growing interest from smartphone OEMs ...
(Date:6/15/2015)... 15, 2015 A new report [ ... the majority of US consumers using mobile banking applications want ... as fingerprint and voiceprint, instead of having to prove who ... Telstra,s " Mobile Identity   -   The Fusion of ... smartphones now the primary channel used by Gen X and ...
(Date:6/11/2015)... Daon, a global leader in mobile ... Mobile Authentication Platform v4.0 has been FIDO Certified™.  ... industry consortium launched in 2013 to revolutionize online ... In order to receive certification, a company,s products ... tests that measure compliance and ensure interoperability among ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 375 MSEK 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 4Daon's IdentityX Mobile Authentication Platform One of First Products to be Certified by FIDO Alliance 2
... the central nervous system is injured, oligodendrocyte precursor cells ... sheaths on demyelinated axons. Scientists at the Institute of ... have now discovered that a distinct protein regulates the ... transmembrane protein NG2, which is expressed at the surface ...
... Society of America (ESA) has elected ten new Fellows ... Fellow acknowledges outstanding contributions to entomology in one or ... The following Fellows will be recognized during Entomology 2013 ... held November 10-13, 2013 in Austin, Texas: DR. ...
... trapping the greenhouse gas carbon dioxide deep underground could at ... natural gas liquids from ailing reservoirs, thus offsetting some of ... paper to be published in the peer-reviewed International Journal ... "fracking" as a method for extracting previously untapped fossil fuel ...
Cached Biology News:Scientists at Mainz University decode mechanisms of cell orientation in the brain 2Entomological Society of America announces 2013 fellows 2Entomological Society of America announces 2013 fellows 3Entomological Society of America announces 2013 fellows 4Entomological Society of America announces 2013 fellows 5Entomological Society of America announces 2013 fellows 6Entomological Society of America announces 2013 fellows 7Entomological Society of America announces 2013 fellows 8Entomological Society of America announces 2013 fellows 9Entomological Society of America announces 2013 fellows 10Entomological Society of America announces 2013 fellows 11Entomological Society of America announces 2013 fellows 12Entomological Society of America announces 2013 fellows 13Entomological Society of America announces 2013 fellows 14Entomological Society of America announces 2013 fellows 15Entomological Society of America announces 2013 fellows 16Entomological Society of America announces 2013 fellows 17Sequestration and fuel reserves 2
...
... contains 5 ml of DETACHaBEAD Mouse CD4, ... CD4+ T cells from Dynabeads Mouse CD4 ... T cells from Dynabeads Mouse CD4 using ... suitable for any downstream application including flow ...
Request Info...
TEMPLIPHI HT SEQ AMPL KIT, 1 EA. Category: Sequencing Template Amplification....
Biology Products: